AstraZeneca Pharma India has informed that at the Board meeting of the Company held on Monday, November 11, 2019, the Board of Directors considered and approved the Unaudited Financial Results of the Company for the quarter ended September 30, 2019. The said Unaudited Financial Results together with the Limited Review report of the Statutory Auditors dated November 11, 2019 are enclosed herewith.
The above information is a part of company’s filings submitted to BSE.